Cargando…

Surgical Management of Retroperitoneal Sarcoma

Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominguez, Dana A., Sampath, Sagus, Agulnik, Mark, Liang, Yu, Nguyen, Bao, Trisal, Vijay, Melstrom, Laleh G., Lewis, Aaron G., Paz, Isaac Benjamin, Roberts, Randall F., Tseng, William W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217420/
https://www.ncbi.nlm.nih.gov/pubmed/37232807
http://dx.doi.org/10.3390/curroncol30050349
_version_ 1785048533444853760
author Dominguez, Dana A.
Sampath, Sagus
Agulnik, Mark
Liang, Yu
Nguyen, Bao
Trisal, Vijay
Melstrom, Laleh G.
Lewis, Aaron G.
Paz, Isaac Benjamin
Roberts, Randall F.
Tseng, William W.
author_facet Dominguez, Dana A.
Sampath, Sagus
Agulnik, Mark
Liang, Yu
Nguyen, Bao
Trisal, Vijay
Melstrom, Laleh G.
Lewis, Aaron G.
Paz, Isaac Benjamin
Roberts, Randall F.
Tseng, William W.
author_sort Dominguez, Dana A.
collection PubMed
description Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments.
format Online
Article
Text
id pubmed-10217420
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102174202023-05-27 Surgical Management of Retroperitoneal Sarcoma Dominguez, Dana A. Sampath, Sagus Agulnik, Mark Liang, Yu Nguyen, Bao Trisal, Vijay Melstrom, Laleh G. Lewis, Aaron G. Paz, Isaac Benjamin Roberts, Randall F. Tseng, William W. Curr Oncol Review Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments. MDPI 2023-04-29 /pmc/articles/PMC10217420/ /pubmed/37232807 http://dx.doi.org/10.3390/curroncol30050349 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dominguez, Dana A.
Sampath, Sagus
Agulnik, Mark
Liang, Yu
Nguyen, Bao
Trisal, Vijay
Melstrom, Laleh G.
Lewis, Aaron G.
Paz, Isaac Benjamin
Roberts, Randall F.
Tseng, William W.
Surgical Management of Retroperitoneal Sarcoma
title Surgical Management of Retroperitoneal Sarcoma
title_full Surgical Management of Retroperitoneal Sarcoma
title_fullStr Surgical Management of Retroperitoneal Sarcoma
title_full_unstemmed Surgical Management of Retroperitoneal Sarcoma
title_short Surgical Management of Retroperitoneal Sarcoma
title_sort surgical management of retroperitoneal sarcoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217420/
https://www.ncbi.nlm.nih.gov/pubmed/37232807
http://dx.doi.org/10.3390/curroncol30050349
work_keys_str_mv AT dominguezdanaa surgicalmanagementofretroperitonealsarcoma
AT sampathsagus surgicalmanagementofretroperitonealsarcoma
AT agulnikmark surgicalmanagementofretroperitonealsarcoma
AT liangyu surgicalmanagementofretroperitonealsarcoma
AT nguyenbao surgicalmanagementofretroperitonealsarcoma
AT trisalvijay surgicalmanagementofretroperitonealsarcoma
AT melstromlalehg surgicalmanagementofretroperitonealsarcoma
AT lewisaarong surgicalmanagementofretroperitonealsarcoma
AT pazisaacbenjamin surgicalmanagementofretroperitonealsarcoma
AT robertsrandallf surgicalmanagementofretroperitonealsarcoma
AT tsengwilliamw surgicalmanagementofretroperitonealsarcoma